Welch Group’s Boston Scientific BSX Stock Holding History

Welch Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$228K	Buy	+5,223	New	+$242K	0.01%	296
2026 Q2	–	Sell	-4,287	Closed	-$269K	–	327
2026 Q1	$269K	Sell	4,287 -431	-9%	-$34.5K	0.01%	248
2025 Q4	$450K	Buy	4,718 +77	+2%	+$7.55K	0.02%	186
2025 Q3	$453K	Hold	4,641	–	–	0.02%	181
2025 Q2	$498K	Buy	4,641 +159	+4%	+$16.1K	0.02%	158
2025 Q1	$445K	Sell	4,482 -57	-1%	-$5.74K	0.02%	156
2024 Q4	$407K	Buy	4,539 +1,882	+71%	+$166K	0.02%	169
2024 Q3	$223K	Hold	2,657	–	–	0.01%	243
2024 Q2	$205K	Buy	+2,657	New	+$194K	0.01%	247

Other funds holding BSX

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Welch Group's BSX Position: Q3 2026 in Review

Welch Group opened a new position in Boston Scientific (BSX) in Q3 2026: 5,223 shares worth $228K. The stake represents 0.01% of the portfolio and ranks #296 among its holdings. This is a return to the name: Welch Group previously reported a position in BSX as recently as Q1 2026.

Welch Group first reported a position in BSX in Q2 2024 and has held it in 9 quarters since. The position peaked at $498K in Q2 2025. 802 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

Welch Group held 5,223 shares of Boston Scientific worth $228K as of Q3 2026.
Boston Scientific was a new Welch Group position in Q3 2026.
Boston Scientific made up 0.01% of Welch Group's portfolio in Q3 2026, its #296 holding.
Welch Group first reported a position in Boston Scientific in Q2 2024 and has held it in 9 quarters since.
Welch Group's Boston Scientific position peaked at $498K in Q2 2025.
802 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Welch Group's 13F filing for Q3 2026, filed 29 Oct 2026.